Recce Pharmaceuticals

<b>Recce Pharmaceuticals and its Board of Directors are committed to achieving and implementing effective corporate governance practises to ensure the organisation is managed in an effective, transparent and ethical manner.

The Company continues to monitor and report against current ASX Corporate Governance Principles and Recommendations.

2023 Annual General Meeting

Corporate Governance Statement from Recce's Annual Report

Company Constitutions

Board Charters

Company Code of Conduct

Audit & Risk Management Committee Charter

Nomination & Remuneration Committee Charter

Trading Policy

Diversity Policy

Continuous Disclosure Policy

Shareholder Communication Strategy

Risk Management Policy

Whistleblower Policy

Anti-bribery and Corruption Policy 

Skills Matrix

Learn about Recce Pharmaceuticals' corporate governance practices, ensuring transparency, accountability, and long-term value for investors

Corporate Governance

News and Media

Announcements

Titillium Web

Recce's Entitlement Offer is now live! Visit the page for instructions on how to participate

Recce Pharmaceuticals follows good corporate governance practices, which include the adoption of committees to provide advice to the full board.

 – responsible for evaluating the performance of the Board and individual Directors on a quarterly basis.

Audit and Risk Committee Management Committee

 – responsible for the robustness of the various internal control systems it has in place to safeguard the integrity of the company’s financial reporting.

Recce Pharmaceuticals actively strives to achieve the core values of integrity, inclusivity, innovation, respect and accountability at all times.